Drug
nerandomilast
Marketed as JASCAYD.
Generic name
nerandomilast
Brand names
JASCAYD
First FDA approval
2025-10-07
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA218764 | JASCAYD | 2025-10-07 | BOEHRINGER INGELHEIM |
Manufacturers
BOEHRINGER INGELHEIM
Frequently asked questions
When was nerandomilast FDA approved?
Earliest FDA approval on record: 2025-10-07.
What brand names are sold as nerandomilast?
JASCAYD.
Sources
Appeal a nerandomilast denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com